News and Opinions

by Charles Bankhead - MedPageToday - Long-term survival in the CARTITUDE-1 trial showed that almost half of patients remained, alive with a median overall survival (OS) of 60.7 months. Almost three-fourths of the survivors remained progression free, and more than a...

By Julie Grisham - Memorial Sloan Kettering Cancer Center - When it comes to giving immunotherapy to people with the most common form of lymphoma, the time of day may make a difference, according to new research from Memorial Sloan Kettering Cancer Center (MSK)....

By Chinese Academy of Sciences - SciTechDaily - A new method for engineering natural killer cells could make cancer immunotherapy more efficient, scalable, and affordable, potentially reshaping how these treatments are produced. Chinese scientists have reported a new...

By Frank Vinluan - MedCity News - A rare but severe stem cell transplant complication that often becomes fatal now has its first FDA-approved treatment, a therapy developed by biotechnology company Omeros. Omeros’s complement system drug Yartemlea is now FDA approved...

By Matt Hoffman - CGTlive - As 2025 comes to a close, CGTLive has looked back on some of the most-read and most impactful FDA regulatory decisions and news in the cell and gene therapy space. These approvals and regulatory actions marked major progress for patients...

By Genetic Engineering adn Biotechnology News - Cancer immunotherapy transforms a patient’s immune cells into a “search‑and‑destroy” force against tumors. But many cancers learn to camouflage themselves from dendritic cells—the immune system’s scouts—making them...

by Tel-Aviv University - MedXpress - A new international study led by Prof. Carmit Levy of the Department of Human Genetics and Biochemistry at the Gray Faculty of Medical & Health Sciences at Tel Aviv University finds that melanoma cancer cells paralyze immune...

By William A. Haseltine, - Forbes - Treating brain diseases is extraordinarily challenging, because drugs often work poorly and implants require risky surgery that can jeopardize critical brain functions. A group at MIT has sought a different approach, using the...

By Anne Trafton, Massachusetts Institute of Technology - ScitTechDaily - As the immune system weakens with age, researchers have found a way to temporarily boost its function by reprogramming liver cells to support T-cell development. As people get older, the immune...

By Drug Target Review - Kobe University researchers have developed a new way of freeze induced pluripotent stem cells (iPS cells) directly in their culture dishes without losing viability or pluripotency. Researchers at Kobe University have developed a novel method...

by Science Daily - Researchers have revealed that so-called “junk DNA” contains powerful switches that help control brain cells linked to Alzheimer’s disease. By experimentally testing nearly 1,000 DNA switches in human astrocytes, scientists identified around 150...

by ScienceBlog - Researchers at the University of Illinois Urbana-Champaign have engineered a solution using tiny microgels packed with antioxidant crystals. Published in Advanced Functional Materials, their work demonstrates how a single dose of these protective...

By Danny Sullivan - Longevity.Technology - Healthspan as a universal right, the need for new regulation, the age of mitochondrial therapies and 7 shifts to accelerate longevity. As we reflect on some of the interviews we’ve conducted over the past 12 months, it’s...

By Cleveland Clinic - Patient with quadruple refractory multiple myeloma achieves complete response with cell therapy A Cleveland Clinic patient participated in a clinical trial of allogenic CAR T-cell therapy to treat highly resistant multiple myeloma and achieved a...

by James Lim, PhD - The Scientist - Let’s face it: Nobody pursues a career in science for the joy of culturing cells. But this thankless and time-intensive task is the backbone of biological research. When it’s done extremely well, the results generated from...

By UCI Health News - CIRM award will support first-of-its-kind clinical trial in humans This award will support a first-in-human safety and tolerability study of an embryonic stem cell-derived neural stem cell product for Huntington’s disease, a milestone for patients...

By Mayo Clinic - A Mayo Clinic study published in the September 2025 issue of Science Advances explores a novel approach to retinal gene therapy using fibrin hydrogels encapsulating adeno-associated virus 2-green fluorescent protein (AAV2-GFP). The findings suggest a...

By Heidi Borst - Forbes - Human longevity has reached new heights. During the 20th century, lifespan in high-income countries increased by about 30 years due to public health and medicine advancements, according to a 2024 analysis in Nature Aging.[1] In the U.S., the...

By Sriparna Roy - Reuters News - Regeneron (REGN.O), opens new tab said on Saturday its experimental cancer combination therapy was effective and showed disappearance of the disease in previously untreated patients with a type of blood cancer in the first part of a...

by Mark Johnson - MSN - Aging taps us on the shoulder in many ways: wrinkles, thinning hair, loss of flexibility, slowing of the brain. But the process also unfolds at a more fundamental, microscopic level, as the energy source inside most cells deteriorates....